New blood prep tool could make cancer detection easier
NCT ID NCT05942066
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called See.d that processes whole blood into slides and plasma for liquid biopsy. Researchers want to see if the device can standardize sample preparation, making it easier to detect cancer cells or DNA in the blood. The study involves 200 healthy adults and focuses on the quality and stability of the processed samples.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could make liquid biopsies more reliable and easier to use for detecting diseases like cancer from a blood sample.
- What could go wrong
- This is an early feasibility study with healthy volunteers, not patients. It only tests the device's ability to process blood, not to diagnose or treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ospedale San Raffaele
RECRUITINGMilan, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates